Target intelligence / Profile preview

Dietary carbohydrate absorption

Molecular classification
Other (physiological process)
01

Overview

Dietary carbohydrate absorption is not a single molecule or receptor but rather a physiological process involving the enzymatic breakdown of dietary polysaccharides and disaccharides into monosaccharides—primarily glucose, galactose, and fructose—which are then absorbed across the small intestinal epithelium. The digestion begins in the mouth with salivary amylase acting on starches but primarily occurs in the small intestine via pancreatic amylase. Final hydrolysis to monosaccharides is performed by brush border enzymes such as maltase, sucrase, lactase, and isomaltase[1][2][3][5].\n\nAbsorption mechanisms differ for each sugar:\n\n- Glucose and galactose are absorbed via active transport through SGLT1 (sodium-glucose co-transporter 1), coupled with sodium ions.\n \n- Fructose is absorbed by facilitated diffusion through GLUT5 transporter.\n\nAll three sugars exit enterocytes into portal circulation via GLUT2 transporter[2][4][5].\n\nThis process ensures efficient uptake of dietary carbohydrates for use as energy or storage. Disruption can lead to clinical conditions like malabsorption syndromes or contribute to metabolic diseases if excessive.\n\n**Note:** \"Dietary carbohydrate absorption\" refers to a biological function/process rather than a discrete molecular target such as an enzyme or receptor. Therefore it should not be considered a canonical therapeutic target itself but may be modulated indirectly by drugs targeting specific enzymes involved in this pathway[2].

Other names
Carbohydrate absorptionIntestinal carbohydrate absorptionAbsorption of dietary carbohydrates
02

Mechanism of action

Inhibition of brush border enzymes (e.g., alpha-glucosidase) to delay breakdown of complex carbohydrates into absorbable monosaccharides

03

Biological functions

Nutrient uptakeEnergy metabolismGlucose homeostasisDigestion and transport of monosaccharides
04

Disease associations

Diabetes mellitus (impaired or excessive absorption can affect glycemic control)Malabsorption syndromes (e.g., celiac disease, lactose intolerance)Obesity and metabolic syndrome (through effects on energy balance)
05

Safety considerations

For drugs targeting this process, gastrointestinal side effects such as flatulence and diarrhea are common due to undigested carbohydrates reaching the colon.
06

Interacting drugs

Acarbose

2 more in the full profile.

Beyond the preview

Go deeper on Dietary carbohydrate absorption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary carbohydrate absorption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call